SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
批准号:
6735630
负责人:
PETER D WALZER
金额:
$38.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2007-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pneumocystis carinii (Pc) is a fungus of low virulence that is major cause of
pneumonia (P) in HIV patients. Surfactant protein (SP-A), a member of the
collectins, plays an important role in the host's innate immunity against
pulmonary pathogens. Studies of the interaction of SP-A with Pc have mainly
been conducted in vitro and have produced conflicting results. Gene targeted
mice deficient in SP-A appear more susceptible to PcP than wild type mice
administered the same immunosuppression. The application proposes the
following hypotheses: SP-A facilitates the clearance of Pc in the
immunocompetent host; this activity can be localized to specific domains of
SP-A and is mediated at least in part by alveolar macrophages; SP-A delays the
development and reduces the severity of PcP in the immunocompromised host;
SP-A down regulates the host immune/inflammatory response to Pc. The specific
aims are: 1) To analyze the effects of SP-A on Pc infection in the
immunocompetent host. These studies will: 1.1) investigate the effects of
SP-A on the clearance of Pc from the lungs; 1.2) determine if the
administration of SP-A can reverse the changes in SP-A deficient mice and to
localize the specific domains involved; 1.3) study the effects of SP-A on the
interaction of Pc with alveolar macrophages; and 1.4) analyze the effects of
SP-A on the host immune/inflammatory response to Pc infection. 2) To analyze
the effects of SP-A on PcP in the immunocompromised host. These studies will:
2.1) analyze the effects of SP-A on the development of PcP induced by
different forms of immunosuppression; 2.2) examine the influence of SP-A on
the changes in alveolar cells, sufactant constituents, and lung function that
occur with PcP; and 2.3) analyze the influence of SP-A on the host
immune/inflammatory response that occurs during the recovery from PcP.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sensitized splenocytes result in deleterious cytokine cascade and hyperinflammatory response in rats with Pneumocystis pneumonia despite the presence of corticosteroids.
尽管存在皮质类固醇,但敏化的脾细胞仍会导致肺孢子虫肺炎大鼠产生有害的细胞因子级联反应和高炎症反应。
DOI:
10.1128/iai.72.2.757-765.2004
发表时间:
2004
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Thullen,TimothyD, Ashbaugh,AlanD, Daly,KieranR, Linke,MichaelJ, Steele,PaulE, Walzer,PeterD]
通讯作者:
Walzer,PeterD
Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression.
停用皮质类固醇诱导的免疫抑制后,鼠肺孢子虫感染得到缓解。
DOI:
10.1016/j.micpath.2005.10.002
发表时间:
2006
期刊:
Microbial pathogenesis
影响因子:
3.8
作者:
[Linke,Michael, Ashbaugh,Alan, Demland,Jeffery, Koch,Judith, Tanaka,Reiko, Walzer,Peter]
通讯作者:
Walzer,Peter
Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.
环境暴露后,小鼠肺孢子虫在免疫活性表面活性蛋白 A 缺陷小鼠中定植。
DOI:
10.1186/1465-9921-10-10
发表时间:
2009-02-19
期刊:
Respiratory research
影响因子:
5.8
作者:
[Linke MJ, Ashbaugh AD, Demland JA, Walzer PD]
通讯作者:
Walzer PD
New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies.
抗CD4(+)T淋巴细胞抗体诱导肺孢子虫肺炎新大鼠模型。
DOI:
10.1128/iai.71.11.6292-6297.2003
发表时间:
2003
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Thullen,TimothyD, Ashbaugh,AlanD, Daly,KieranR, Linke,MichaelJ, Steele,PaulE, Walzer,PeterD]
通讯作者:
Walzer,PeterD
Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo.
抗人类免疫缺陷病毒药物在体外和体内对卡氏肺孢子虫均无效。
DOI:
10.1086/323991
发表时间:
2001
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
[Walzer,PD, Ashbaugh,A, Collins,M, Cushion,MT]
通讯作者:
Cushion,MT
共 6 条
Serum Antibodies to Recombinant Pneumocystis Antigens
-
批准号:7188525
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2005
-
负责人:PETER D WALZER
-
依托单位:
Serum Antibodies to Recombinant Pneumocystis Antigens
-
批准号:7585265
-
项目类别:
-
资助金额:$46.77万
-
财政年份:2005
-
负责人:PETER D WALZER
-
依托单位:
Global Serological Study of Pneumocystis Infection
-
批准号:7114021
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:PETER D WALZER
-
依托单位:
Global Serological Study of Pneumocystis Infection
-
批准号:6934161
-
项目类别:
-
资助金额:$6.74万
-
财政年份:2005
-
负责人:PETER D WALZER
-
依托单位:
Serum Antibodies to Recombinant Pneumocystis Antigens
-
批准号:7388815
-
项目类别:
-
资助金额:$45.48万
-
财政年份:2005
-
负责人:PETER D WALZER
-
依托单位:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
-
批准号:6077013
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:PETER D WALZER
-
依托单位:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
-
批准号:6638606
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:PETER D WALZER
-
依托单位:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
-
批准号:6390669
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:PETER D WALZER
-
依托单位:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
-
批准号:6537755
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2000
-
负责人:PETER D WALZER
-
依托单位:
PNEUMOCYSITIS CARINII INFECTION THERAPIES--PRECLIN EVAL
-
批准号:6334487
-
项目类别:
-
资助金额:$33.61万
-
财政年份:1997
-
负责人:PETER D WALZER
-
依托单位:
PNEUMOCYSITIS CARINII INFECTION THERAPIES--PRECLIN EVAL
-
批准号:2658860
-
项目类别:
-
资助金额:$31.32万
-
财政年份:1997
-
负责人:PETER D WALZER
-
依托单位:
PNEUMOCYSITIS CARINII INFECTION THERAPIES--PRECLIN EVAL
-
批准号:6158374
-
项目类别:
-
资助金额:$32.45万
-
财政年份:1997
-
负责人:PETER D WALZER
-
依托单位:
PNEUMOCYSITIS CARINII INFECTION THERAPIES--PRECLIN EVAL
-
批准号:2651634
-
项目类别:
-
资助金额:$30.24万
-
财政年份:1997
-
负责人:PETER D WALZER
-
依托单位:
METABOLIC STUDIES OF OPPORTUNISTIC FUNGI AND PROTOZOA
-
批准号:3547869
-
项目类别:
-
资助金额:$79.83万
-
财政年份:1991
-
负责人:PETER D WALZER
-
依托单位:
METABOLIC STUDIES OF OPPORTUNISTIC FUNGI AND PROTOZOA
-
批准号:3547868
-
项目类别:
-
资助金额:$69.04万
-
财政年份:1991
-
负责人:PETER D WALZER
-
依托单位:
METABOLIC STUDIES OF OPPORTUNISTIC FUNGI AND PROTOZOA
-
批准号:2066669
-
项目类别:
-
资助金额:$77.87万
-
财政年份:1991
-
负责人:PETER D WALZER
-
依托单位:
DEVELOPMENT OF ADDITIONAL DRUGS FOR PENUMOCYSTIS CARINII
-
批准号:3596108
-
项目类别:
-
资助金额:$31.11万
-
财政年份:1987
-
负责人:PETER D WALZER
-
依托单位:
DEVELOPMENT OF ADDITIONAL DRUGS FOR PENUMOCYSTIS CARINII
-
批准号:3596106
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1987
-
负责人:PETER D WALZER
-
依托单位:
DEVELOPMENT OF ADDITIONAL DRUGS FOR PENUMOCYSTIS CARINII
-
批准号:3596107
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1987
-
负责人:PETER D WALZER
-
依托单位:
DEVELOPMENT OF ADDITIONAL DRUGS FOR PENUMOCYSTIS CARINII
-
批准号:3596111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1987
-
负责人:PETER D WALZER
-
依托单位:
海外基金